AMANDA STRICKLAND: Open Payments
NPI 1285117630 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 47 payments from 20 companies in 2025. Trend: 2023 $1,712 · 2024 $212 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $111 |
| PFIZER INC. | 4 | $81 |
| ABBVIE INC. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| SK Life Science, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| MDD US Operations, LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: XIFAXAN, Zilbrysq, Rystiggo, NURTEC ODT, INGREZZA, REXULTI, AUSTEDO XR, UBRELVY.
Industry payments across GA — which companies pay providers there.
